Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Natalie Bavli"'
Autor:
Pallavi Dev, Natalie Bavli, Brittney Sims, Jenny Foster, Anna Moscowitz, Una E. Makris, Siayareh Rambally
Publikováno v:
eJHaem, Vol 5, Iss 1, Pp 131-135 (2024)
Abstract There is a paucity of data regarding the use of non‐pharmacologic therapies for pain in sickle cell disease. The purpose of this pilot study was to assess the acceptability and feasibility of video‐guided mindfulness meditation, breathin
Externí odkaz:
https://doaj.org/article/9324e22bff774f1b9412c1d49c55a5fe
Autor:
Vincent T. Ho, Haesook T. Kim, Natalie Bavli, Martin Mihm, Olga Pozdnyakova, Matthias Piesche, Heather Daley, Carol Reynolds, Nicholas C. Souders, Corey Cutler, John Koreth, Edwin P. Alyea, Joseph H. Antin, Jerome Ritz, Glenn Dranoff, Robert J. Soiffer
Publikováno v:
Blood Advances, Vol 1, Iss 24, Pp 2269-2279 (2017)
Abstract: We report a clinical trial testing vaccination of autologous myeloblasts admixed with granulocyte-macrophage colony-stimulating factor secreting K562 cells after allogeneic hematopoietic stem cell transplantation (HSCT). Patients with myelo
Externí odkaz:
https://doaj.org/article/b9cd8c81fce84bbb89eabfa774379357
Autor:
Natalie Bavli, Ravi Sarode
Publikováno v:
Rossi's Principles of Transfusion Medicine. :443-452
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2b41d40f0ed74f79aff6ae62e589ef5
https://doi.org/10.1002/9781119719809.ch38
https://doi.org/10.1002/9781119719809.ch38
Autor:
Nicholas C.J. Lee, Natalie Bavli, Sean Yates, Michael Harms, Kavita Bhavan, Andrew Quinn, Ibrahim F. Ibrahim
Publikováno v:
Blood. 140:11334-11336
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c642704a45b1ce8fc52980f001f597c3
https://doi.org/10.1182/blood-2022-168113
https://doi.org/10.1182/blood-2022-168113
Autor:
Nicholas C.J. Lee, Natalie Bavli, Sean Yates, Michael Harms, Kavita Bhavan, Andrew Quinn, Ibrahim F. Ibrahim
Publikováno v:
Blood. 140:11337-11338
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d83eb25976481c8dedc16c57f149bc7
https://doi.org/10.1182/blood-2022-168204
https://doi.org/10.1182/blood-2022-168204
Publikováno v:
Blood. 140:11122-11123
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a10ed0f2eff1e5f0bbfea5e02cf24e3
https://doi.org/10.1182/blood-2022-170564
https://doi.org/10.1182/blood-2022-170564
Autor:
Nicholas C.J. Lee, Sean Yates, Siayareh Rambally, Ravindra Sarode, Ibrahim F. Ibrahim, Yu-Min Shen, Sandra L. Hofmann, Natalie Bavli
Publikováno v:
Blood. 140:2693-2694
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ddb5aa02dab23b16d838dafcde073bf9
https://doi.org/10.1182/blood-2022-165329
https://doi.org/10.1182/blood-2022-165329
Publikováno v:
British Journal of Haematology. 196
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ccc72e9e648176496f4e7312f86f86b2
https://doi.org/10.1111/bjh.17917
https://doi.org/10.1111/bjh.17917
Publikováno v:
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 60(6)
Autoimmune thrombotic thrombocytopenic purpura (aTTP) is caused by autoantibodies to the von Willebrand Factor cleaving enzyme, ADAMTS13. Despite recent advances in the treatment of acute aTTP, relapse rates remain high. Guidance for the treatment of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::633fd054c91270064b30196c2b923381
https://pubmed.ncbi.nlm.nih.gov/34400095
https://pubmed.ncbi.nlm.nih.gov/34400095
Autor:
Pavan Bachireddy, Nathan Mathewson, Samuel S. Freeman, Arman W. Mohammad, Nikolaos Barkas, Donna Neuberg, Gad Getz, Natalie Bavli, Kendell Clement, Juliet Forman, Jennifer R. Brown, Thomas J. Kipps, Liudmila Elagina, Christina Ennis, Vincent T. Ho, Sachet A. Shukla, Edwin P. Alyea, Jerome Ritz, Robert J. Soiffer, Ignaty Leshchiner, Laura Z. Rassenti, Catherine J. Wu, Vinhkhang N Nguyen, Derin B. Keskin, Peter V. Kharchenko, Andreas Gnirke, Satyen H. Gohil
Publikováno v:
Science translational medicine, vol 12, iss 561
Sci Transl Med
Sci Transl Med
Leukemic relapse remains a major barrier to successful allogeneic hematopoietic stem cell transplantation (allo-HSCT) for aggressive hematologic malignancies. The basis for relapse of advanced lymphoid malignancies remains incompletely understood and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5536a2cf37addc9c92e0cc331a2c012
https://doi.org/10.1126/scitranslmed.abb7661
https://doi.org/10.1126/scitranslmed.abb7661